scispace - formally typeset
A

Aminah Jatoi

Researcher at Mayo Clinic

Publications -  440
Citations -  15796

Aminah Jatoi is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 46, co-authored 404 publications receiving 12708 citations. Previous affiliations of Aminah Jatoi include University of Texas Health Science Center at San Antonio & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Hospice in End-of-Life Patients With Cancer: Does It Lead to Changes in Nonhospice Health Care Utilization After Stopping Cancer Treatment?

Carmen Radecki Breitkopf, +2 more
- 01 Jun 2014 - 
TL;DR: Hospice was associated with a drop in nonhospice-related health care utilization, thus suggesting it provides timely medical interventions and favorable continuity of care.
Journal Article

Using the absolute neutrophil count as a stand-alone test in a hematology/oncology clinic: an abbreviated test can be preferable.

Aminah Jatoi, +3 more
- 01 Jan 1998 - 
TL;DR: It is concluded that the absolute neutrophil count can be used widely in the hematology/oncology clinic as a separate, stand-alone test and its popularity over the five-part differential may be based on the fact that the ANC is a focused test with a relatively short TAT.
Journal ArticleDOI

Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials

Quyen Duong, +6 more
- 01 Dec 2021 - 
TL;DR: Of note, phase of trial was associated with consent form length (phase III were wordier), and consent forms manifested a consistent increase in wordiness over time, highlighting a timely need to find ways to limit the verbosity of consent forms, particularly in those from pharmaceutical company trials.
Journal ArticleDOI

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

Aminah Jatoi, +5 more
- 17 Jun 2009 - 
TL;DR: In this cohort of geriatric lung cancer patients – all of whom were treated during a clinical trial – there was a high level of social support, however, there were no gender-based differences in extent of socialSupport, and the latter did not predict clinical outcomes.
Journal ArticleDOI

Do older patients with non-small cell lung cancer also benefit from first-line platinum-based doublet chemotherapy? Observations from a pooled analysis of 730 prospectively-treated patients (Alliance Study A151622).

Josephine Feliciano, +11 more
- 01 Sep 2018 - 
TL;DR: Findings support carboplatin doublet-based chemotherapy in select older patients with advanced NSCLC.